financetom
Business
financetom
/
Business
/
BMO on Sleep Country's Q4
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO on Sleep Country's Q4
Mar 8, 2024 11:07 AM

01:56 PM EST, 03/08/2024 (MT Newswires) -- Sleep Country reported a Q4/23 earnings beat. However, macro weighed on SSSG (-3.2%, above -7.5% forecast). BMO notes that the macro backdrop to remain unpredictable through 2024E.

"In the meantime, Sleep Country is well-positioned to weather the weakness and achieve market share gains for everything "sleep", while continuing to invest in its sleep ecosystem," writes analyst Stephen MacLeod.

Acquisitions and strategic initiatives position Sleep Country well for 2024E+.

Maintain Outperform, $35 target.

Price: 28.58, Change: -0.60, Percent Change: -2.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salesforce Q1 Results Likely to Exceed Low Expectations, Oppenheimer Says
Salesforce Q1 Results Likely to Exceed Low Expectations, Oppenheimer Says
May 23, 2024
02:40 PM EDT, 05/23/2024 (MT Newswires) -- Salesforce ( CRM ) fiscal Q1 results are expected to surpass already low expectations, Oppenheimer said in a note Thursday. The company expects Q1 adjusted earnings per share of $2.37 to $2.39 on revenue of $9.12 billion to $9.17 billion. Salesforce ( CRM ) is expected to report Q1 results on Wednesday, and...
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
May 23, 2024
On Wednesday, Royalty Pharma plc ( RPRX ) and Cytokinetics ( CYTK ) Incorporated entered into a strategic funding collaboration providing capital to support the commercialization of aficamten and advance the company’s expanding cardiovascular pipeline. The transaction includes funding for planned commercialization, development funding, royalty restructuring, revenue sharing, and the purchase of Cytokinetics ( CYTK ) equity.  Together, these provide Cytokinetics ( CYTK ) with $250 million on...
BHP's Spinoff South32 Eyes Anglo American's Manganese Assets
BHP's Spinoff South32 Eyes Anglo American's Manganese Assets
May 23, 2024
South32 ( SHTLF ) Ltd (OTCPK: SHTLF), the diversified mining company spun out of BHP Group Ltd in 2015, has expressed interest in acquiring Anglo American's share of their jointly owned manganese assets. While BHP's acquisition efforts mainly focus on prized copper assets, Anglo American also announced restructuring amidst a strategic focus on copper and iron ore. “At the right...
Charter Communications Prices Tender Offer for Senior Secured Notes due 2025
Charter Communications Prices Tender Offer for Senior Secured Notes due 2025
May 23, 2024
02:43 PM EDT, 05/23/2024 (MT Newswires) -- Charter Communications ( CHTR ) said Thursday it has determined a total early offer consideration of $993.94 per $1,000 principal amount of notes in the tender offer for the company's outstanding 4.908% senior secured notes due 2025. The tender offer comprises the offer to purchase for cash up to $2.7 billion, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved